Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Nabriva Therapeutics AG (NBRV)  
$0.39 0.00 (0.00%) as of 4:30 Wed 12/2


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 150,780,000
Market Cap: 59.38(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.3938 - $0.3938
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Nabriva Therapeutics is a holding company. Through its subsidiaries, Co. is a biopharmaceutical company engaged in the research, development and commercialization of anti-infective agents to treat serious infections. Co. has approval from the U.S. Food and Drug Administration for XENLETA for the treatment of adults with community-acquired bacterial pneumonia. XENLETA is an oral and intravenous treatment in the pleuromutilin class of antibiotics available for the systematic administration in humans. Co.'s CONTEPO is a potentially epoxide antibiotic for intravenous use in the U.S. for complicated urinary tract infections. Co. may develop XENLETA and CONTEPO for additional indications.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 51,839
Total Sell Value $0 $0 $0 $9,588
Total People Sold 0 0 0 6
Total Sell Transactions 0 0 0 6
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 323
  Page 3 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Gelone Steven P. President and COO   •       •      –    2022-03-06 4 D $0.43 $38 D/D (89) 362,211     -
   Gelone Steven P. President and COO   •       •      –    2022-02-28 4 D $0.45 $27 D/D (61) 362,300     -
   Schroeder Theodore R Chief Executive Officer   •       •      –    2022-02-28 4 D $0.45 $56 D/D (125) 314,223     -
   Gelone Steven P. President and COO   •       •      –    2022-02-06 4 D $0.48 $51 D/D (106) 362,361     -
   Schroeder Theodore R Chief Executive Officer   •       •      –    2022-02-06 4 D $0.48 $126 D/D (263) 314,348     -
   Gelone Steven P. President and COO   •       •      –    2022-01-31 4 D $0.48 $35 D/D (73) 362,467     -
   Schroeder Theodore R Chief Executive Officer   •       •      –    2022-01-31 4 D $0.48 $60 D/D (125) 314,611     -
   Gelone Steven P. President and COO   •       •      –    2022-01-29 4 D $0.45 $1,567 D/D (3,483) 362,540     -
   Schroeder Theodore R Chief Executive Officer   •       •      –    2022-01-29 4 D $0.45 $4,845 D/D (10,766) 314,736     -
   Schroeder Theodore R Chief Executive Officer   •       •      –    2022-01-06 4 D $0.58 $157 D/D (270) 325,502     -
   Gelone Steven P. President and COO   •       •      –    2022-01-06 4 D $0.58 $64 D/D (110) 366,023     -
   Schroeder Theodore R Chief Executive Officer   •       •      –    2021-12-31 4 D $0.60 $64 D/D (107) 325,772     -
   Gelone Steven P. President and COO   •       •      –    2021-12-31 4 D $0.60 $38 D/D (63) 366,133     -
   Schroeder Theodore R Chief Executive Officer   •       •      –    2021-12-28 4 B $0.57 $57,320 D/D 100,000 325,879 2.81 -100%     
   Naftzger J. Christopher General Counsel and Corp Sec   •       –      –    2021-12-27 4 B $0.59 $4,130 D/D 7,000 7,000 2.66 -100%     
   Gelone Steven P. President and COO   •       •      –    2021-12-06 4 D $0.72 $66 D/D (92) 366,196     -
   Schroeder Theodore R Chief Executive Officer   •       •      –    2021-12-06 4 D $0.72 $162 D/D (225) 225,879     -
   Schroeder Theodore R Chief Executive Officer   •       •      –    2021-11-30 4 D $0.78 $83 D/D (107) 226,104     -
   Gelone Steven P. President and COO   •       •      –    2021-11-30 4 D $0.78 $49 D/D (63) 366,288     -
   Schroeder Theodore R Chief Executive Officer   •       •      –    2021-11-06 4 D $1.33 $299 D/D (225) 226,211     -
   Gelone Steven P. President and COO   •       •      –    2021-11-06 4 D $1.33 $122 D/D (92) 366,351     -
   Schroeder Theodore R Chief Executive Officer   •       •      –    2021-10-06 4 D $1.08 $243 D/D (225) 226,543     -
   Gelone Steven P. President and COO   •       •      –    2021-10-06 4 D $1.08 $99 D/D (92) 366,506     -
   Schroeder Theodore R Chief Executive Officer   •       •      –    2021-09-30 4 D $1.19 $127 D/D (107) 226,768     -
   Gelone Steven P. President and COO   •       •      –    2021-09-30 4 D $1.19 $75 D/D (63) 366,598     -

  323 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 3 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed